Leptin receptor deficiency is associated with upregulation of cannabinoid 1 receptors in limbic brain regions
- 24 June 2008
- Vol. 62 (9) , 637-642
- https://doi.org/10.1002/syn.20531
Abstract
Leptin receptor dysfunction results in overeating and obesity. Leptin regulates hypothalamic signaling that underlies the motivation to hyperphagia, but the interaction between leptin and cannabinoid signaling is poorly understood. We evaluated the role of cannabinoid 1 receptors (CB1R) in overeating and the effects of food deprivation on CB1R in the brain. One‐month‐old Zucker rats were divided into unrestricted and restricted (fed 70% of unrestricted rats) diet groups and maintained until adulthood (4 months). Levels of relative binding sites of CB1R (CB1R binding levels) were assessed using [3H] SR141716A in vitro autoradiography. These levels were higher (except cerebellum and hypothalamus) at 4 months than at 1 month of age. One month CB1R binding levels for most brain regions did not differ between Ob and Lean (Le) rats (except in frontal and cingulate cortices in Le and in the hypothalamus in Ob). Four month Ob rats had higher CB1R binding levels than Le in most brain regions and food restriction was associated with higher CB1R levels in all brain regions in Ob, but not in Le rats. CB1R binding levels increased between adolescence and young adulthood which we believe was influenced by leptin and food availability. The high levels of CB1R in Ob rats suggest that leptin's inhibition of food‐intake is in part mediated by downregulation of CB1R and that leptin interferes with CB1R upregulation under food‐deprivation conditions. These results are consistent with prior findings showing increased levels of endogenous cannabinoids in the Ob rats corroborating the regulation of cannabinoid signaling by leptin. Synapse 62:637–642, 2008. Published 2008 Wiley‐Liss, Inc.Keywords
This publication has 39 references indexed in Scilit:
- Cannabinoid-1 Receptor Antagonist, Rimonabant, for Management of Obesity and Related RisksCirculation, 2006
- Development of insulin resistance and hyperphagia in Zucker fatty ratsAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2006
- ??9-THC induced hyperphagia and tolerance assessment: interactions between the CB1 receptor agonist ??9-THC and the CB1 receptor antagonist SR-141716 (rimonabant) in ratsBehavioural Pharmacology, 2005
- The anti‐obesity effect of rimonabant is associated with an improved serum lipid profileDiabetes, Obesity and Metabolism, 2004
- Cannabinoid (CB)1 receptor antagonist, AM 251, causes a sustained reduction of daily food intake in the ratPhysiology & Behavior, 2004
- Cannabinoid (CB)1 receptor antagonist, AM 251, causes a sustained reduction of daily food intake in the ratPhysiology & Behavior, 2004
- CB1 Receptor Knockout Mice Display Reduced Ethanol-Induced Conditioned Place Preference and Increased Striatal Dopamine D2 ReceptorsNeuropsychopharmacology, 2004
- Anandamide administration into the ventromedial hypothalamus stimulates appetite in ratsBritish Journal of Pharmacology, 2001
- Phenotypes of Mouse diabetes and Rat fatty Due to Mutations in the OB (Leptin) ReceptorScience, 1996
- The Zucker fatty rat as a genetic model of obesity and hypertension.Hypertension, 1989